The Urethral Dilator Market is being driven by Prevalence of minimally invasive procedures
The Urethral Dilator Market is expected to grow at a CAGR of 6.05% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 104.8 million. In the dynamic urethral dilator market, vendors are strategically investing in the development of technologically advanced urology surgery supplies to secure substantial market shares. Manufacturers are prioritizing R&D activities to introduce innovative products featuring enhanced operative flexibility. Key offerings in the urology surgery supplies sector comprise urethral dilators, access sheaths, urethral catheters, and guidewires. Notably, Allium Medical, a leading player in urethral dilators, recently unveiled its new line of urological stents, named Allium's urological stents, designed for treating ureteral fistulas. This strategic product expansion underscores the industry's commitment to improving the diagnosis and treatment of urological disorders.
Get more information on Urethral Dilator Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
165 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.05% |
Market growth 2024-2028 |
USD 104.8 million |
Market structure |
fragmentation |
YoY growth 2023-2024(%) |
5.35 |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Urethral Dilator Market is witnessing significant growth due to the increasing prevalence of medical conditions such as Benign Prostatic Hyperplasia (BPH) in the geriatric population, Urinary Incontinence (UI), and Urinary Tract Infections (UTIs) in hospitals like Mount Sinai. The market is also driven by the high patient volume due to elective surgeries for medical conditions like kidney stones, prostate cancer, and urethral strictures. The recurrence of these conditions and surgical-related infections are major factors fueling the demand for urethral dilators. Factors such as birth defects, trauma, inflammation, fibrosis, and chronic kidney diseases also contribute to the market growth. Healthcare companies are investing in research and development to produce advanced urethral dilators to address the unique needs of patients. However, lockdown restrictions and surgical cancellations due to the COVID-19 pandemic have impacted the market growth. The baby boomer population's increasing prevalence of urinary diseases, urinary stones, and chronic kidney diseases will continue to drive the market in the forecast period.
According to Technavio, the global urethral dilator market is a segment of the expansive healthcare equipment market. This market encompasses entities involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, implants, accessories, and consumables. These products are utilized in the diagnosis, monitoring, and treatment of diverse disease areas. The size of the global healthcare equipment market is determined by the consolidated revenue generated by manufacturers of diagnostic equipment and devices. The healthcare equipment sector encompasses the following segments: Devices, which include advanced, differentiated, and clinically validated data-driven devices. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted